SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-22-226088
Filing Date
2022-08-22
Accepted
2022-08-22 09:08:18
Documents
4
Group Members
INNOVIVA ACQUISITION SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d382789dsctota.htm SC TO-T/A 23378
2 EX-99.(A)(5)(B) d382789dex99a5b.htm EX-99.(A)(5)(B) 11903
3 GRAPHIC g382789g0821221808040.jpg GRAPHIC 2963
4 GRAPHIC g382789g0821221808149.jpg GRAPHIC 631
  Complete submission text file 0001193125-22-226088.txt   42380
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-44849 | Film No.: 221182375
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations